[
  {
    "date": "2023-12-30",
    "symbol": "TCBP",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2023,
    "currentfiscalyearenddate": "--12-31",
    "entityfilenumber": "001-41231",
    "entityregistrantname": "TC BIOPHARM (HOLDINGS) PLC",
    "entitycentralindexkey": 1872812,
    "entitytaxidentificationnumber": "00-0000000",
    "entityincorporationstatecountrycode": "X0",
    "entityaddressaddressline1": "Maxim                                             1, 2 Parklands Way",
    "entityaddressaddressline2": "Holytown",
    "entityaddresscityortown": "Motherwell",
    "entityaddresscountry": "GB",
    "entityaddresspostalzipcode": "ML1 4WR",
    "cityareacode": "+44 (0)",
    "localphonenumber": "141 433 7557",
    "security12btitle": "American     Depositary Shares, each representing one Ordinary Share, nominal value £0.0001 per share",
    "tradingsymbol": "TCBP",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "true",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorfirmid": 688,
    "auditorname": "Marcum LLP",
    "auditorlocation": "New York, NY",
    "cashandcashequivalentsatcarryingvalue": 2462609,
    "corporationtaxreceivable": 1043593,
    "prepaidexpenseandotherassetscurrent": 2194725,
    "assetscurrent": 5700927,
    "propertyplantandequipmentnet": 1274798,
    "operatingleaserightofuseasset": 1340769,
    "intangibleassetsnetexcludinggoodwill": 615170,
    "assets": 8931664,
    "accountspayableandaccruedliabilitiescurrent": 4431840,
    "derivativeliabilitiescurrent": 13437,
    "operatingleaseliabilitycurrent": 305324,
    "liabilitiescurrent": 4750601,
    "operatingleaseliabilitynoncurrent": 1495833,
    "liabilities": 6246434,
    "commonstockvalue": 2057,
    "deferredstockvalue": 397398,
    "additionalpaidincapital": 41123065,
    "retainedearningsaccumulateddeficit": -38837290,
    "stockholdersequity": 2685230,
    "liabilitiesandstockholdersequity": 8931664,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 20570088,
    "commonstocksharesissued": 20570088,
    "commonstocksharesoutstanding": 20570088,
    "deferredstockparorstatedvaluepershare": 0.4999,
    "deferredstocksharesauthorized": 794955,
    "deferredstocksharesissued": 794955,
    "deferredstocksharesoutstanding": 794955,
    "researchanddevelopmentexpense": 7771391,
    "generalandadministrativeexpense": 6467932,
    "operatingexpenses": 14239323,
    "operatingincomeloss": -14239323,
    "gainslossesonextinguishmentofdebt": -645845,
    "derivativegainlossonderivativenet": 8052581,
    "foreigncurrencytransactiongainlossbeforetax": -80070,
    "interestexpense": 83025,
    "nonoperatingincomeexpense": 7243641,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -6995682,
    "incometaxexpensebenefit": -1088729,
    "netincomeloss": -5906953,
    "weightedaveragenumberofsharesoutstandingbasic": 6178423,
    "weightedaveragenumberofdilutedsharesoutstanding": 6178423,
    "earningspersharebasic": -0.96,
    "earningspersharediluted": -0.96,
    "sharesoutstanding": 20570088,
    "stockissuedduringperiodvaluesharebasedcompensation": 444459,
    "stockissuedduringperiodvaluenewissues": 1962,
    "stockissuedduringperiodsharesnewissues": 19620130,
    "adjustmentstoadditionalpaidincapitalreclassificationofwarrantstoequity": 1550367,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 1032979,
    "depreciation": 596726,
    "amortizationofintangibleassets": 36282,
    "sharebasedcompensation": 444459,
    "othernoncashexpense": 71568,
    "increasedecreaseinincorporationtaxreceivable": -676407,
    "increasedecreaseinprepaidexpensesother": 1275269,
    "increasedecreaseinoperatingleaseliabilityrightofuseasset": -189505,
    "increasedecreaseinaccountspayableandaccruedliabilities": 2272782,
    "increasedecreaseinoperatingleaseliability": -323711,
    "netcashprovidedbyusedinoperatingactivities": -10544870,
    "paymentstoacquirepropertyplantandequipment": 110353,
    "paymentstoacquireintangibleassets": 98436,
    "netcashprovidedbyusedininvestingactivities": -208789,
    "repaymentsofconvertibledebt": 639336,
    "proceedsfromissuanceofwarrants": 5127260,
    "proceedsfromissuanceofcommonstock": 4186862,
    "paymentsofstockandwarrantissuancecosts": 793746,
    "netcashprovidedbyusedinfinancingactivities": 8520376,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -112168,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -2345451,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 2462609,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.37,
    "warrantsandrightsoutstandingterm": "P4Y3M18D",
    "workingcapitaldeficit": 1000000,
    "propertyplantandequipmentusefullife": "P4Y",
    "effectiveincometaxratereconciliationtaxcredits": 0.3335,
    "cashfdicinsuredamount": 200000,
    "cashuninsuredamount": 2300000,
    "finitelivedintangibleassetusefullife": "P16Y",
    "propertyplantandequipmentgross": 4979026,
    "propertyplantandequipmentadditions": 91724,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 3731217,
    "finitelivedintangibleassetsgross": 49613,
    "finitelivedintangibleassetsacquired1": 98436,
    "finitelivedintangibleassetsaccumulatedamortization": 49613,
    "otherreceivables": 51584,
    "valueaddedtaxreceivable": 135642,
    "prepaidclinicaltrialcosts": 307519,
    "deferredclinicaltrialtestingcosts": 1177500,
    "otherprepaidexpensecurrent": 522480,
    "accountspayabletradecurrent": 1847279,
    "accrualfortaxesotherthanincometaxescurrent": 139029,
    "accruedliabilitiescurrent": 1229419,
    "accruedinrespecttoclinicaltrialtesting": 1177500,
    "accountspayableothercurrent": 38613,
    "convertibledebt": 809692,
    "operatingleaseweightedaverageremainingleaseterm1": "P5Y1M9D",
    "operatingleaseweightedaveragediscountratepercent": 0.086,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 447015,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 447015,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 447015,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 447015,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 447015,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 433919,
    "operatingleaseliability": 1801156,
    "operatingleaseexpense": 402314,
    "operatingleasepayments": 447015,
    "accruedinterestconvertibledebt": 71568,
    "modificationofloannotesconvertibledebt": -53619,
    "currencyadjustmentconvertibledebt": -32097,
    "warrantsandrightsoutstandingmeasurementinput": 100,
    "shareprice": 215,
    "stockissued1": 3800000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 5329,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 460,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 35125,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 674,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 4240,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 5329,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 460,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsunexercisablenumber": 284,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsunexercisableweightedaverageexerciseprice": 4240,
    "allocatedsharebasedcompensationexpense": 444459,
    "weightedaveragefairvalueofoptions": 62.12,
    "currentfederaltaxexpensebenefit": 1088729,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -1643985,
    "incometaxreconciliationprioryearincometaxes": -45136,
    "incometaxreconciliationnondeductibleexpense": 1497764,
    "valuationallowancedeferredtaxassetchangeinamount": 357897,
    "incometaxreconciliationforeignincometaxratedifferential": 29318,
    "valuationallowancedeferredtaxassetother": 233096,
    "incometaxreconciliationotheradjustments": 241704,
    "incometaxreconciliationtaxcreditsresearch": 1043593,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.235,
    "deferredtaxassetnetoperationlosses": 4357668,
    "deferredtaxassetspropertyplantandequipment": 79338,
    "deferredtaxassetsother": 17946,
    "deferredtaxassetsgross": 4454952,
    "deferredtaxassetsvaluationallowance": 4454952,
    "operatinglosscarryforwards": 16400000
  },
  {
    "date": "2022-12-31",
    "symbol": "TCBP",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "documentperiodenddate": "2022-12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2022,
    "currentfiscalyearenddate": "--12-31",
    "entityfilenumber": "001-41231",
    "entityregistrantname": "TC BIOPHARM (HOLDINGS) PLC",
    "entitycentralindexkey": 1872812,
    "entityaddressaddressline1": "Maxim 1, 2 Parklands Way",
    "entityaddressaddressline2": "Holytown",
    "entityaddresscityortown": "Motherwell",
    "entityaddresscountry": "GB",
    "entityaddresspostalzipcode": "ML1 4WR",
    "countryregion": "+44 (0)",
    "cityareacode": 141,
    "localphonenumber": "433 7557",
    "security12btitle": "American     Depositary Shares, each representing one Ordinary Share, nominal value £0.0001 per share",
    "tradingsymbol": "TCBP",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "entityshellcompany": "false",
    "entitycommonstocksharesoutstanding": 949958,
    "contactpersonnelname": "Bryan Kobel",
    "contactpersonnelemailaddress": "b.kobel@tcbiopharm.com",
    "auditorname": "Marcum LLP",
    "auditorfirmid": 688,
    "auditorlocation": "New York, NY",
    "revenue": 3844532,
    "researchanddevelopmentexpense": 7447507,
    "administrativeexpense": 7013056,
    "administrativeexpensescostsrelatedtolisting": 1305087,
    "foreignexchangeloss": 120974,
    "profitlossfromoperatingactivities": -15886624,
    "gainslossesonmodificationofconvertibleloan": -140344,
    "gainslossesonchangeinfairvalueofderivatives": 7112034,
    "gainslossesonchangeinfairvalueofwarrantderivatives": 12785290,
    "gainslossesonchangeinfairvalueofotherderivatives": -3832379,
    "financeincome": 2208,
    "financecosts": 6994423,
    "profitlossbeforetax": -3109706,
    "incometaxexpensecontinuingoperations": -1720000,
    "profitloss": -1389706,
    "basicearningslosspershare": -2.02,
    "intangibleassetsotherthangoodwill": 553016,
    "rightofuseassets": 1188947,
    "propertyplantandequipment": 1761171,
    "noncurrentassets": 3503134,
    "tradeandothercurrentreceivables": 919456,
    "currenttaxassetscurrent": 1720000,
    "cashandcashequivalents": 4808060,
    "currentassets": 7447516,
    "assets": 10950650,
    "issuedcapital": 397493,
    "sharepremium": 16597811,
    "retainedearnings": -33731738,
    "otherreserves": 16710757,
    "equity": -25677,
    "noncurrentleaseliabilities": 1812450,
    "noncurrentliabilities": 1812450,
    "tradeandothercurrentpayables": 2159058,
    "currentconvertibleloan": 653484,
    "currentderivativefinancialliabilities": 2439,
    "currentwarrantderivativeliabilities": 6020863,
    "currentleaseliabilities": 328033,
    "currentliabilities": 9163877,
    "liabilities": 10976327,
    "equityandliabilities": 10950650,
    "increasedecreasethroughsharebasedpaymenttransactions": 1123250,
    "issueofequity": 202017,
    "adjustmentsfordepreciationexpense": 714550,
    "adjustmentsamortizationofintangibleassets": 55046,
    "adjustmentsforamortizationofrightofuseassets": 196577,
    "adjustmentsforsharebasedpayments": 1123250,
    "gainslossesonchangeinfairvalueofwarrants": 12785290,
    "gainslossesonchangeinfairvalueofotherderivativeliabilities": -3832379,
    "adjustmentsforunrealisedforeignexchangelossesgains": 120974,
    "adjustmentsforfinancecosts": 6994423,
    "lossondisposaloftangibleassets": 8646,
    "adjustmentsfordecreaseincreaseindecreaseindeferredincome": 3844533,
    "adjustmentsfordecreaseincreaseintradeaccountreceivable": -37503,
    "adjustmentsforincreasedecreaseintradeaccountpayable": -1944557,
    "cashflowsfromusedinoperations": -15649642,
    "interestpaidclassifiedasoperatingactivities": 289912,
    "interestreceivedclassifiedasoperatingactivities": 2208,
    "incometaxespaidrefundclassifiedasoperatingactivities": -1407199,
    "cashflowsfromusedinoperatingactivities": -14530147,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 240712,
    "proceedsfromsalesofpropertyplantandequipmentclassifiedasinvestingactivities": 55000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 124485,
    "cashflowsfromusedininvestingactivities": -310197,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 762150,
    "proceedsfromborrowingsclassifiedasfinancingactivities": 18110,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 2632324,
    "proceedsfromsaleofwarrants": 18806153,
    "proceedsfromissuingshares": 3369877,
    "shareissuecosts": 908602,
    "cashflowsfromusedinfinancingactivities": 17891064,
    "increasedecreaseincashandcashequivalents": 3050720,
    "effectofexchangeratechangesoncashandcashequivalents": 190652,
    "nameofsubsidiary": "TC    BioPharm Limited",
    "countryofincorporationorresidenceofsubsidiary": "United    Kingdom",
    "subsidiaryholding": "Ordinary    £1 shares and A Ordinary £0.001 shares",
    "proportionheld": "100%    by TC BioPharm (Holdings) plc",
    "natureofbusiness": "Biotechnology    research and development",
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P4Y",
    "numberofsharesissued": 24693,
    "exercisepriceshareoptionsgranted2019": 212.5,
    "collaborativecodevelopmentagreements": 73000000,
    "numberofoperatingsegments1": 1,
    "percentageforincometaxlossesforcashrebate": 0.3335,
    "usefullivesoramortizationratesintangibleassetsotherthangoodwill1": "Software is amortized, on a straight-line basis, over the life of the relevant license (3 to 4 years).",
    "remainingamortisationperiodofintangibleassetsmaterialtoentity2019": "P16Y",
    "notesanddebenturesissued": 14228245,
    "repaymentsofsubordinatedliabilities": 3195765,
    "sharenominalvalue": 0.0001,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.85,
    "borrowingsinterestrate": 0.05,
    "percentageofloanissued": 0.5,
    "borrowingsmaturity": "January 18, 2022",
    "revenueestimatedterm": "P6Y",
    "depreciationpropertyplantandequipment": 683475,
    "amortizationofintangibleasset": 55046,
    "amortizationofrightofuseassets": 174954,
    "interestexpenseonleaseliabilities": 260206,
    "otherinterest": 29706,
    "interestonconvertibleloan": 6704511,
    "currenttaxexpenseincome": 1720000,
    "taxexpenseincomeatapplicabletaxrate": 590844,
    "adjustmentsforcurrenttaxofpriorperiod": 154422,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 1834581,
    "superdeductions": 13178,
    "increasedecreasethroughnetexchangedifferencesdeferredtaxliabilityasset": -671566,
    "deferredtaxassetnotrecognized": -186879,
    "additionalallowanceinrespectofenhancedrdrelief": 4198115,
    "surrenderoftaxlossesforrdtaxcreditrefund": -2109111,
    "researchanddevelopmenttaxcreditsgenerated": 1565578,
    "applicabletaxrate": 0.19,
    "numberofemployees": 70,
    "wagesandsalaries": 3512525,
    "socialsecuritycontributions": 432388,
    "postemploymentbenefitexpensedefinedcontributionplans": 156360,
    "expensefromsharebasedpaymenttransactionswithemployees": 403803,
    "employeebenefitsexpense": 4505076,
    "directorsremunerationinrespectofqualifyingservices": 1203537,
    "directorsemployerspensioncontributions": 72176,
    "directorsremunerationexpense": 1275713,
    "unrecognisedtaxrate": 0.3,
    "deferredtaxexpenseincomerelatingtotaxratechangesorimpositionofnewtaxes": 886660,
    "basicanddilutedweightedaveragenumberofsharesoutstanding": 687199,
    "basicanddilutedearningslosspershare": -2.02,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 124485,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 225666,
    "disposalspropertyplantandequipment": 228026,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": 683592,
    "othercurrentreceivables": 56264,
    "currentvalueaddedtaxreceivables": 27055,
    "currentprepaidclinicaltrialcosts": 307519,
    "currentprepayments": 528618,
    "tradeandothercurrentpayablestotradesuppliers": 882364,
    "currentpayablesonsocialsecurityandtaxesotherthanincometax": 293467,
    "accrualsclassifiedascurrent": 944904,
    "othercurrentpayables": 38323,
    "currentloanandderivativefinancialliabilities": 655923,
    "currentconvertibleloannotesissued": 170,
    "currentderivativefinancialliabilitiesnotesissued": 17940,
    "currentloanandderivativefinancialliabilitiesloansnotesissued": 18110,
    "currentconvertibleloanaccruedinterest": 6704511,
    "currentloanandderivativefinancialliabilitiesaccruedinterest": 6704511,
    "currentconvertibleloanconversionofloannotes": -10506174,
    "currentloanandderivativefinancialliabilitiesconversionofloannote": -10506174,
    "currentconvertibleloanrepaymentofloannotes": -2632324,
    "currentloanandderivativefinancialliabilitiesrepaymentofloannote": -2632324,
    "currentconvertibleloanmodification": -30535,
    "currentderivativefinancialliabilitiesmodification": 170879,
    "currentloanandderivativefinancialliabilitiesmodification": 140344,
    "currentderivativefinancialliabilitiesfairvalueadjustment": -7112034,
    "currentloanandderivativefinancialliabilitiesfairvalueadjustment": -7112034,
    "currentconvertibleloancurrencyadjustment": 311626,
    "currentloanandderivativefinancialliabilitiescurrencyadjustment": 311626,
    "decreasethroughclassifiedasheldforsalepropertyplantandequipment": 36643,
    "lossesondisposalsofpropertyplantandequipment": 8646,
    "exercisepriceofconvertibledebt": 0.5,
    "shareprice2019": 3.85,
    "borrowingstimetomaturity": "P0Y1M6D",
    "descriptionofexpectedvolatility": 1,
    "descriptionofriskfreeinterestrate": 0.041,
    "fairvalueofwarrantsissuedinperiod": 20872152,
    "weightedaveragesharepriceshareoptionsgranted2019": 3.85,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.04,
    "fairvalueofwarrantpricepershare": 0.03,
    "adjustmentsforgainslossesonchangeinfairvalueofderivatives": 3832379,
    "reallocationofderivativeliabilitiestoequity": -3832379,
    "issuepricepershare": 212,
    "exchangedrate": 1,
    "undiscountedoperatingleasepaymentstobereceived": 495482,
    "interestonleaseliabilities": 167449,
    "leasesliabilities": 328033,
    "leaseliabilities": 43073,
    "rightofuseassetsincreasedecrease": -192469,
    "amountrecognizedofinterestexpensesandvariableleasepayments": 456783,
    "currentcontractliabilitiesreleasedtothestatementofprofitorloss": -3844533,
    "gainslossesarisingfromsaleandleasebacktransactions": 43073,
    "cashoutflowforleases": 762150,
    "interestexpenseonlease": 260206,
    "deferredtaxlossescarriedforward": 17733217,
    "unrecognizeddeferredtaxassetrate": 0.25,
    "unrecognizeddeferredtaxasset": 4433305,
    "sharecapitalandpremium": 16995304,
    "numberofsharesoutstanding": 949958,
    "parvaluepershare": 0.0001,
    "issuedordinarycapital": 95,
    "issueofordinarysharesnumberofshares": 559006,
    "issuedcapitalordinaryshare": 202017,
    "issueofordinarysharessharepremium": 16597811,
    "redesignationofnominalvaluetodeferredsharesnumberofshares": 794955,
    "redesignationofnominalvaluetodeferredsharesnumberofsharesordinarysharecapital": -397398,
    "redesignationofnominalvaluetodeferredsharesnumberofsharesdeferredsharecapital": 397398,
    "deferredsharecapital": 397398,
    "furtherpaymentsofordinaryshares": 100000000,
    "issuedpricepershare": 215,
    "numberofoutstandingshareoptions": 106585,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 23,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 52305,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 212,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 106585,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 23,
    "numberofshareoptionsnotexercisableinsharebasedpaymentarrangement": 28737,
    "weightedaverageexercisepriceofshareoptionsnotexercisablesharebasedpaymentarrangement2019": 212,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 1627103,
    "keymanagementpersonnelcompensationsharebasedpayment": 1123250,
    "keymanagementpersonnelcompensation": 2750353,
    "weightedaverageshareprice2019": 53.42,
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 1123250,
    "tradeandotherpayablestotradesuppliers": 882364,
    "convertibleloans": 655923,
    "otherpayables": 1276694,
    "financialliabilities": 2814981,
    "currentleaseliabilitiescashflows": 762150,
    "currentleaseliabilitiesother": 324425,
    "convertibleloannotescurrent": 655923,
    "convertibleloannotescashflows": -2632324,
    "convertibleloannotesother": -10443617,
    "noncurrentleaseliabilitiesother": 324425,
    "leaseliabilitiescashflows": 3394474,
    "leaseliabilitiesother": -10443617,
    "convertibleloan": 6470,
    "convertibleloannotes": 6601,
    "derivativefinancialliabilities": 407512
  },
  {
    "date": "2021-12-31",
    "symbol": "TCBP",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "documentperiodenddate": "2021-12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2021,
    "currentfiscalyearenddate": "--12-31",
    "entityfilenumber": "001-41231",
    "entityregistrantname": "TC BIOPHARM (HOLDINGS) PLC",
    "entitycentralindexkey": 1872812,
    "entityaddressaddressline1": "Maxim 1, 2 Parklands Way",
    "entityaddressaddressline2": "Holytown",
    "entityaddresscityortown": "Motherwell",
    "entityaddresscountry": "GB",
    "entityaddresspostalzipcode": "ML1 4WR",
    "countryregion": "+44 (0)",
    "cityareacode": 141,
    "localphonenumber": "433 7557",
    "security12btitle": "American     Depositary Shares, each representing one Ordinary Share, nominal value £0.01 per share",
    "tradingsymbol": "TCBP",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "entityshellcompany": "false",
    "entitycommonstocksharesoutstanding": 19547600,
    "contactpersonnelname": "Bryan Kobel",
    "contactpersonnelemailaddress": "b.kobel@tcbiopharm.com",
    "icfrauditorattestationflag": "false",
    "auditorfirmid": 1438,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Edinburgh, United Kingdom",
    "revenue": 1978659,
    "researchanddevelopmentexpense": 6156889,
    "administrativeexpense": 2058844,
    "administrativeexpensescostsrelatedtolisting": 1049950,
    "foreignexchangeloss": 82764,
    "othergainslosses": 6381,
    "profitlossfromoperatingactivities": -9342066,
    "gainslossesonchangeinfairvalueofderivatives": -4181545,
    "financeincome": 33,
    "financecosts": 3438548,
    "profitlossbeforetax": -14983467,
    "incometaxexpensecontinuingoperations": -1407542,
    "profitloss": -13575925,
    "basicanddilutedearningslosspershare": -0.7,
    "intangibleassetsotherthangoodwill": 483577,
    "rightofuseassets": 1385524,
    "propertyplantandequipment": 2298655,
    "noncurrentassets": 4167756,
    "tradeandothercurrentreceivables": 881953,
    "currenttaxassetscurrent": 1407199,
    "cashandcashequivalents": 1566688,
    "currentassets": 3855840,
    "assets": 8023596,
    "issuedcapital": 195476,
    "retainedearnings": -33465282,
    "otherreserves": 16710757,
    "equity": -16559049,
    "deferredtaxliabilities": 1865873,
    "noncurrentleaseliabilities": 2136875,
    "noncurrentliabilities": 4002748,
    "currentdeferredtaxliabilities": 1978660,
    "tradeandothercurrentpayables": 4103615,
    "currentderivativefinancialliabilities": 6925654,
    "currentconvertibleloan": 6806210,
    "currentleaseliabilities": 765758,
    "currentliabilities": 20579897,
    "liabilities": 24582645,
    "equityandliabilities": 8023596,
    "shareissuerelatedcost": 896,
    "adjustmentsfordepreciationexpense": 765031,
    "adjustmentsamortizationofintangibleassets": 63451,
    "adjustmentsforamortizationofrightofuseassets": 196576,
    "adjustmentsforunrealisedforeignexchangelossesgains": 64983,
    "adjustmentsforfinancecosts": 3438548,
    "adjustmentsfordecreaseincreaseindecreaseindeferredincome": 1978659,
    "adjustmentsfordecreaseincreaseintradeaccountreceivable": -591617,
    "adjustmentsforincreasedecreaseintradeaccountpayable": 2338197,
    "cashflowsfromusedinoperations": -6505445,
    "interestpaidclassifiedasoperatingactivities": 254653,
    "interestreceivedclassifiedasoperatingactivities": 33,
    "incometaxespaidrefundclassifiedasoperatingactivities": -1179043,
    "cashflowsfromusedinoperatingactivities": -5581022,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 20033,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 123191,
    "cashflowsfromusedininvestingactivities": -143224,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 122469,
    "proceedsfromborrowingsclassifiedasfinancingactivities": 6383659,
    "proceedsfromissuingshares": 285108,
    "shareissuecosts": 21160,
    "cashflowsfromusedinfinancingactivities": 6525138,
    "increasedecreaseincashandcashequivalents": 800892,
    "effectofexchangeratechangesoncashandcashequivalents": 17781,
    "nameofsubsidiary": "TC BioPharm Limited",
    "countryofincorporationorresidenceofsubsidiary": "United Kingdom",
    "subsidiaryholding": "Ordinary £1 shares    and A Ordinary £0.001 shares",
    "proportionheld": "100%",
    "natureofbusiness": "Biotechnology research    and development",
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P4Y",
    "otherinflowsoutflowsofcashclassifiedasoperatingactivities": -5300000,
    "currentassetsexcludingconvertibleloannotes": 3900000,
    "currentliabilitiesexcludingconvertibleloannotes": 6800000,
    "issueofconvertibleinstruments": 8800000,
    "interestrateforfacevalueofnotes": 0.5,
    "notesanddebenturesissued": 2,
    "proceedsfromissueofbondsnotesanddebentures": 1,
    "loanspayableindefault": 17700000,
    "cashreceiptsfromrepaymentofadvancesandloansmadetootherpartiesclassifiedasinvestingactivities": 8800000,
    "conversionpriceforadssandwarrantsdescription": "Unless otherwise agreed between the Company and the individual Note holders the outstanding Notes willconvert into ADSs and Warrants (at a conversion price of 1 ADS and 2 Warrants per $4.25 of the face value of the converted Notes, plus5% interest accruing) in May and August 2022, and, if not converted or renegotiated, they will become repayable at their face value (plus5% interest accruing).",
    "borrowings": 2400000,
    "numberofoperatingsegments1": 1,
    "percentageforincometaxlossesforcashrebate": 0.3335,
    "usefullivesoramortisationratesintangibleassetsotherthangoodwill1": "Software is amortized, on a straight-line basis, over the life of the relevant license (3 to 4 years).",
    "remainingamortisationperiodofintangibleassetsmaterialtoentity2019": "P16Y",
    "revenuefromcontractswithcustomers": 505191,
    "adjustmentsforincreasedecreaseindeferredincomeincludingcontractliabilities": 5191,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.7,
    "borrowingsinterestrate": 0.05,
    "percentageofloanissued": 0.5,
    "borrowingsmaturity": "January18, 2022",
    "transactionpriceallocatedtoremainingperformanceobligations": 3844532,
    "revenueestimatedterm": "P6Y",
    "grantincome": 6381,
    "otheroperatingincomeexpense": 6381,
    "depreciationpropertyplantandequipment": 730730,
    "amortizationofintangibleasset": 63451,
    "amortizationofrightofuseassets": 174953,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": -17781,
    "interestexpenseonleaseliabilities": 254653,
    "interestonconvertibleloan": 3183895,
    "currenttaxexpenseincome": 1407542,
    "taxexpenseincomeatapplicabletaxrate": 2846859,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 1641974,
    "deferredtaxmovementonunrecognizedfixedassetdifferences": -103418,
    "increasedecreasethroughnetexchangedifferencesdeferredtaxliabilityasset": 42462,
    "deferredtaxassetnotrecognized": -342227,
    "additionalallowanceinrespectofenhancedrdrelief": 1042213,
    "surrenderoftaxlossesforrdtaxcreditrefund": -1843915,
    "researchanddevelopmenttaxcreditsgenerated": 1407542,
    "applicabletaxrate": 0.19,
    "unrecognisedtaxrate": 0.3,
    "deferredtaxexpenseincomerelatingtotaxratechangesorimpositionofnewtaxes": 1025688,
    "numberofemployees": 61,
    "wagesandsalaries": 2989066,
    "socialsecuritycontributions": 313138,
    "postemploymentbenefitexpensedefinedcontributionplans": 94938,
    "employeebenefitsexpense": 3397142,
    "directorsremunerationinrespectofqualifyingservices": 1046324,
    "directorsemployerspensioncontributions": 15001,
    "directorsremunerationexpense": 1061325,
    "basicanddilutedweightedaveragenumberofsharesoutstanding": 19529260,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 123191,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 6825,
    "decreasethroughclassifiedasheldforsalepropertyplantandequipment": 325935,
    "currentvalueaddedtaxreceivables": 70650,
    "currentprepaidclinicaltrialcosts": 336770,
    "currentprepayments": 474533,
    "tradeandothercurrentpayablestotradesuppliers": 1422393,
    "currentpayablesonsocialsecurityandtaxesotherthanincometax": 311204,
    "accrualsclassifiedascurrent": 2330582,
    "othercurrentpayables": 39436,
    "currentloanandderivativefinancialliabilities": 13731864,
    "currentconvertibleloannotesissued": 3540349,
    "currentderivativefinancialliabilitiesnotesissued": 2744109,
    "currentloanandderivativefinancialliabilitiesloansnotesissued": 6284458,
    "currentconvertibleloanaccruedinterest": 3183894,
    "currentloanandderivativefinancialliabilitiesaccruedinterest": 3183894,
    "currentderivativefinancialliabilitiesfairvalueadjustment": 4181545,
    "currentloanandderivativefinancialliabilitiesfairvalueadjustment": 4181545,
    "currentconvertibleloancurrencyadjustment": 81967,
    "currentloanandderivativefinancialliabilitiescurrencyadjustment": 81967,
    "exercisepriceofconvertibledebt": 4.82,
    "shareprice2019": 8,
    "borrowingstimetomaturity": "P1M",
    "descriptionofexpectedvolatility": 0.71,
    "descriptionofriskfreeinterestrate": 0.0008,
    "probabilityasatreportingdateofipocompletion": 0.75,
    "residualloancostscapitalised": 17244578,
    "notionalamount": 17657808,
    "numberofsharesissuedandvested": 120000000,
    "borrowingcostscapitalised": 100000,
    "effectiveinterestrateoffinancialassetsreclassifiedoutofavailableforsalefinancialassets": 0.28,
    "percentageofsharespriceassumptions": 0.25,
    "estimatedvalueofembeddedderivative": 3800000,
    "undiscountedoperatingleasepaymentstobereceived": 1010039,
    "interestonleaseliabilities": 244281,
    "leasesliabilities": 765758,
    "leaseliabilities": 541209,
    "rightofuseassetsincreasedecrease": -192469,
    "amountrecognizedofinterestexpensesandvariableleasepayments": 451229,
    "gainslossesarisingfromsaleandleasebacktransactions": 279142,
    "cashoutflowforleases": 122469,
    "interestexpenseonlease": 254653,
    "currentcontractliabilities": 3844533,
    "currentcontractliabilitiesreleasedtothestatementofprofitorloss": 1978659,
    "deferredtaxlossescarriedforward": 14326058,
    "unrecognizeddeferredtaxassetrate": 0.25,
    "unrecognizeddeferredtaxasset": 3581514,
    "sharebasedpayment": 1546929,
    "numberofsharesissued": 17813020,
    "parvaluepershare": 0.01,
    "numberofoutstandingshareoptions": 19547600,
    "numberofvalueoutstandingshareoptions": 195476,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 10,
    "numberofshareoptionsissuedinsharebasedpaymentarrangement": 89560,
    "numberofshareoptionsissuedvalueinsharebasedpaymentarrangement": 896,
    "issuedpricepershare": 4.3,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 0.46,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 5329230,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 0.46,
    "weightedaverageshareprice2019": 1.18,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P6Y",
    "reversesharesplitdescription": "10for 1 share split",
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 1061325,
    "keymanagementpersonnelcompensation": 1061325,
    "interestexpense": 52795,
    "tradeandotherpayablestorelatedparties": 591886,
    "tradeandotherpayablestotradesuppliers": 1422393,
    "convertibleloans": 13731864,
    "otherpayables": 2681223,
    "financialliabilities": 17835480,
    "currentleaseliabilitiescashflows": 122469,
    "currentleaseliabilitiesother": 445525,
    "convertibleloannotescurrent": 13731864,
    "convertibleloannotescashflows": 6383659,
    "convertibleloannotesother": 7348205,
    "noncurrentleaseliabilitiesother": 445525,
    "leaseliabilitiescashflows": -6261190,
    "leaseliabilitiesother": 7348205,
    "convertibleloan": 67388,
    "derivativefinancialliabilities": 1065684
  }
]